Risk Factors and Incidence for In-Stent Restenosis with Drug-Eluting Stent: A Systematic Review and Meta-Analysis
Reviews in Cardiovascular Medicine · 24.12.2024 · 25 (12)
DOI: 10.31083/j.rcm2512458 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Reviews in Cardiovascular Medicine, online erschienen am 24.12.2024. Verfasst von Birong Liu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, Dongzhimen Hospital, Beijing University of Chinese Medicine, 100700 Beijing, China. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundamental Research Funds for the Central Universities, Beijing University of Chinese Medicine, Youth Fund of the National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
Despite significant reductions in in-stent restenosis (ISR) incidence with the adoption of drug-eluting stents (DES) over bare metal stents (BMS), ISR remains an unresolved issue in the DES era. The risk factors associated with DES-ISR have not been thoroughly analyzed. This meta-analysis aims to identify the key factors and quantify their impact on DES-ISR.
Methods
We conducted comprehensive literature searches in PubMed, EMBASE, Cochrane, and Web of Science up to 28 February 2023, to identify studies reporting risk factors for DES-ISR. Meta-analysis was performed on risk factors reported in two or more studies to determine their overall effect sizes.
Results
From 4357 articles screened, 17 studies were included in our analysis, evaluating twenty-four risk factors for DES-ISR through meta-analysis. The pooled incidence of DES-ISR was approximately 13%, and significant associations were found with seven risk factors. Ranked risk factors included diabetes mellitus (odds ratio [OR]: 1.46; 95% confidence interval [CI]: 1.14–1.87), stent length (OR: 1.026; 95% CI: 1.003–1.050), number of stents (OR: 1.62; 95% CI: 1.11–2.37), involvement of the left anterior descending artery (OR: 1.56; 95% CI: 1.25–1.94), lesion length (OR: 1.016; 95% CI: 1.008–1.024), medical history of myocardial infarction (OR: 1.79; 95% CI: 1.12–2.86) and previous percutaneous coronary intervention (OR: 1.97; 95% CI: 1.53–2.55). Conversely, a higher left ventricular ejection fraction was identified as a protective factor (OR: 0.985; 95% CI: 0.972–0.997).
Conclusions
Despite advancements in stent technology, the incidence of ISR remains a significant clinical challenge. Our findings indicate that patient characteristics, lesion specifics, stent types, and procedural factors all contribute to DES-ISR development. Proactive strategies for early identification and management of these risk factors are essential to minimize the risk of ISR following DES interventions. The PROSPERO Registration: CRD42023427398, https://www.crd.york.ac.uk/PROSPERO/display_record.php?RecordID=427398.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiovascular Medicine, Dongzhimen Hospital, Beijing University of Chinese Medicine, 100700 Beijing, China.
- Department of Cardiovascular Medicine, Xi'an Hospital of Traditional Chinese Medicine, 710001 Xi'an, Shaanxi, China.
- Department of Cardiovascular Medicine, Dongfang Hospital, Beijing University of Chinese Medicine, 100078 Beijing, China.
ORCID-Profile: Birong Liu, Meng Li, Jia Liu, Lihua Xie, Jiaqi Li, Yong Liu, Chaofeng Niu, Di Xiao, Jingen Li, Lijing Zhang
Förderung
- Fundamental Research Funds for the Central Universities, Beijing University of Chinese Medicine
- Youth Fund of the National Natural Science Foundation of China
Zitieren
APA
Liu, B., Li, M., Liu, J., Xie, L., Li, J., Liu, Y., Niu, C., Xiao, D., Li, J., & Zhang, L. (2024). Risk Factors and Incidence for In-Stent Restenosis with Drug-Eluting Stent: A Systematic Review and Meta-Analysis. Reviews in Cardiovascular Medicine, 25(12). https://doi.org/10.31083/j.rcm2512458
Vancouver
Liu B, Li M, Liu J, Xie L, Li J, Liu Y, et al. Risk Factors and Incidence for In-Stent Restenosis with Drug-Eluting Stent: A Systematic Review and Meta-Analysis. Reviews in Cardiovascular Medicine. 2024;25(12). doi:10.31083/j.rcm2512458
BibTeX
@article{Liu2024,
author = {Liu, Birong and Li, Meng and Liu, Jia and Xie, Lihua and Li, Jiaqi and Liu, Yong and Niu, Chaofeng and Xiao, Di and Li, Jingen and Zhang, Lijing},
title = {Risk Factors and Incidence for In-Stent Restenosis with Drug-Eluting Stent: A Systematic Review and Meta-Analysis},
journal = {Reviews in Cardiovascular Medicine},
year = {2024},
volume = {25},
number = {12},
doi = {10.31083/j.rcm2512458}
}
EUVIMED